|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/357 | (2006.01) |
| A61K 9/127 | (2013.01) | ||
| A61K 9/127 | (2006.01) | ||
| A61K 31/357 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Patento numeris | 3449921 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17789632.1 |
| Europos patento paraiškos padavimo data | 2017-04-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-05-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2017/016633 |
| Data | 2017-04-26 |
| (87) | Numeris | WO 2017/188350 |
| Data | 2017-11-02 |
| (30) | Numeris | Data | Šalis |
| 2016091919 | 2016-04-28 | JP |
| (72) |
ASANO, Makoto , JP
MATSUI, Junji , JP
|
| (73) |
Eisai R&D Management Co., Ltd. ,
4-6-10 Koishikawa
Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | ERIBULIN FOR INHIBITING TUMOR GROWTH |
| ERIBULIN FOR INHIBITING TUMOR GROWTH |